I noticed an interesting point - the ROW rights on the timeline is placed before the Prader Willi commencement for Phase 2 trials in Q4 2022....
Does that mean ROW rights is closer than ever? We are now well into Q4 2022...
- Forums
- ASX - By Stock
- NEU
- Ann: Jefferies London Healthcare Conference 2022 presentation
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.40%
!
$13.03

Ann: Jefferies London Healthcare Conference 2022 presentation, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.03 |
Change
0.180(1.40%) |
Mkt cap ! $1.598B |
Open | High | Low | Value | Volume |
$13.15 | $13.15 | $12.92 | $1.856M | 142.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 91 | $13.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.04 | 400 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 181 | 13.050 |
3 | 309 | 13.040 |
4 | 689 | 13.030 |
4 | 1253 | 13.020 |
6 | 1568 | 13.010 |
Price($) | Vol. | No. |
---|---|---|
13.070 | 500 | 1 |
13.080 | 264 | 2 |
13.090 | 1317 | 5 |
13.100 | 1195 | 3 |
13.110 | 594 | 3 |
Last trade - 10.37am 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online